Resverlogix Provides Update Regarding Extension of its Filing Calendar
Confirms Annual Filings on SEDAR Confirms Annual Filings on SEDAR
More:
Resverlogix Provides Update Regarding Extension of its Filing Calendar
Category Archives: Global News Feed
Timber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Virtual Presentation on Wednesday, September 16th at 12:30 PM ET Virtual Presentation on Wednesday, September 16th at 12:30 PM ET
See the rest here:
Timber Pharmaceuticals to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET
AUSTIN, Texas, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it will hold a conference call on Monday, September 14th at 8:30 a.m. Eastern Time.
Read more:
Cassava Sciences to Hold Conference Call on Monday, September 14, 2020 at 8:30 am ET
Avadel to Present at H.C. Wainwright 22nd Annual Global Investment Conference
DUBLIN, Ireland, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the H.C. Wainwright 22nd Annual Global Investment Conference taking place September 14 – 16, 2020.
Read more here:
Avadel to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis
The digital press release with multimedia content can be accessed here:
Novartis data show early treatment with Mayzent® (siponimod) delays disability progression and show benefits in cognitive performance in patients…
The digital press release with multimedia content can be accessed here:
Read the original post:
Novartis data show early treatment with Mayzent® (siponimod) delays disability progression and show benefits in cognitive performance in patients...
Harrow Health to Attend Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
NASHVILLE, Tenn., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending Lake Street’s 4th Annual Best Ideas Growth (BIG4) Conference September 17, 2020, on a virtual platform.
Read the original post:
Harrow Health to Attend Lake Street’s Virtual 4th Annual (BIG4) Conference September 17, 2020
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Company announcement – No. 48 / 2020
Read more from the original source:
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
Todos Medical Announces Commercial Launch of Todos Branded COVID-19 qPCR Test Kits in the United States
NEW YORK, NY, Sept. 11, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that the U.S. Food and Drug Administration (FDA) has added the TODOS 2019-nCoV RT-qPCR Detection Kit to its Notified List under the Emergency Use Authorization program. Todos is required to submit an Emergency Use Authorization application to the FDA within 15 days of submission of the notification.